中文
About Us
About Us
Green Valley is an innovative Chinese pharmaceutical company that pioneers carbohydrate drugs development and manufacturing in the world.
About Green Valley
Our Business
Mission & Vision
Our Culture
Code of Business Ethics
GV-971
GV-971
Here you can get access to more information of GV-971.
Products
News Reports
Research Highlights
Milestones
Scientific Research Information
Scientific Research Information
Originality is the soul of our innovation in scientific research. We are devoted to developing drugs and healthcare solutions that patients are in the greatest need of.
Life Sciences Innovation
Research Parteners
News
News
Here you can get access to the latest news reports of Green Valley.
Press Releases
News Reports
Social Responsibility
Careers
Careers
Apart from the competitive compensation & benefits programs, we have developed a detailed benefits and perks scheme. We respect, appreciate and reward the contributions of every employee for their hard work and dedication.
Job Search
Salary and Benefits
Contact Us
Contact Us
Media Contacts
CN
Mission & Vision
Mission & Vision
About Green Valley
Our Business
Mission & Vision
Our Culture
About Green Valley
Our Business
Mission & Vision
Our Culture
Our Mission
Developing Only the Medicine that Human Beings Most Hope for
Life is a journey of love. Green Valley excels with a perseverance to address unmet treatment needs of complex diseases. To that end, we have been making great efforts to delve into chronic and complex diseases research and carbohydrate drugs development with aiming to improve the quality of life.
Oligomannate TM(GV-971) helps to light up the hope of life for those patients of Alzheimer's disease.
Alzheimer's disease is a chronic, progressively fatal disease. Its pathogenesis is complex with multiple, high-risk pathogenic factors. Every three seconds someone across the globe will be diagnosed with dementia. In 2018, around 50 million patients were affected by dementia worldwide. By 2050, the number may jump to 152 million; three times that of today. It is estimated that the global dementia care expenditure is 1 trillion dollars. This is likely to rise to 2 trillion dollars by 2030.*
Despite the risks of new drug R&D, Green Valley always bears its mission in mind. Green Valley continues to excel with a perseverance to innovate, shouldering the hopes of Alzheimer's patients and their families. After 21-year efforts, GV-971 will help restore the quality of life for more patients and their families afflicted by Alzheimer's disease.
*Data source: World Alzheimer Report, 2018
Our Vision
Being a Global Leader in Carbohydrate Drug Innovation
We are committed to becoming a global leader in carbohydrate drug innovation, providing safer and effective drugs for patients with chronic and complex diseases, and providing better choice of treatment of diseases and improving the quality of life.